A massive multi-center study reveals that the new 2026 AHA/ACC pulmonary embolism framework adds clinical complexity without improving risk prediction for the vast majority of patients.
Hospital administrators are treating clinical artificial intelligence as a cost-saving cure, but the frontline workforce sees a direct threat to patient safety.